X

Procter & Gamble Health Q4FY23 Earnings

P&G Health Ltd. manufactures and sells medications and chemicals.

Financial Results:

  • Procter & Gamble Health Limited reported Total Income for Q4FY23 of ₹ 326 Crores up from ₹ 270 Crore year on year, a rise of 21%.

  • Total Expenses for Q4FY23 of ₹ 247 Crores up from ₹ 205 Crores year on year, rise of 20.5%.

  • Consolidated Net Profit of ₹ 59 Crores, up 16% from ₹ 51 Crores in the same quarter of the previous year.

  • The Earnings per Share is ₹ 35.7, up 16% from ₹ 30.8 in the same quarter of the previous year.
Related Post